• Skip to main content
  • Skip to footer

University of Tennessee Research Foundation

Technology Transfer & Licensing

  • About
    • Our Mission
    • Foundation History & Details
    • Student Opportunities
    • Frequently Asked Questions
    • UTRF Staff
    • Projects & Partners
  • Technologies
    • Available Technologies
    • Express Licensing
  • For Innovators
    • UT Research Foundation Accelerate Fund
    • Resources
    • IDEA Tutorial & Manuals
    • Technology Transfer Process
    • Business Incubator
    • UTRF Technology Maturation Grant Funding
  • Industry
    • Industry Partnerships
    • Agreement Examples
  • Media
    • News
    • Newsletters
    • Tech Talks
    • Annual Reports
  • Contact

UTHSC

UTRF Administrator / May 29, 2023

University of Tennessee Research Foundation, California Institute of Technology secure patent for UT startup’s pancreatic cancer drug

Over half a million people die from cancer every year, according to current statistics. For those diagnosed with pancreatic cancer, the current five-year …

[Read more...] about University of Tennessee Research Foundation, California Institute of Technology secure patent for UT startup’s pancreatic cancer drug

UTRF Administrator / April 25, 2022

UTRF Celebrates Record Number of Licenses, Agreements, Patents at Annual Innovation Awards

This spring, the University of Tennessee Research Foundation was honored to recognize UT innovators from across the state at UTRF’s annual Innovation Awards. …

[Read more...] about UTRF Celebrates Record Number of Licenses, Agreements, Patents at Annual Innovation Awards

UTRF Administrator / April 21, 2022

UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA

UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized …

[Read more...] about UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 37
  • Go to Next Page »

Footer

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Multi Campus Office

400 W. Summit Hill Drive
UT Tower 961A
Knoxville, TN 37902
Phone: 865-974-1882

Health Science Center

UT Health Science Center
910 Madison Avenue, Suite 827
Memphis, TN 38163
Phone: 901-448-7827


Copyright © 2023


University of Tennessee Campuses & Institutes

  • UT Knoxville
  • UT Chattanooga
  • UT Southern
  • UT Martin
  • UT Health Science Center
  • UT Institute of Agriculture
  • UT Institute for Public Service
  • UT Alumni Association
  • UT Foundation
  • UT Research Park
X